Cerebrovascular Disease Monitoring System

POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.

Coagulation testing platform for assessment of blood clotting parameters and hemostatic function. Used for monitoring anticoagulation therapy and diagnosing bleeding or thrombotic disorders.

Digital vascular biomarker platform for arterial health screening and remote cardiovascular monitoring. Enables point-of-care risk stratification, early disease detection, and progression tracking through non-invasive assessment of arterial stiffness and vascular health status.

Portable coagulation monitoring system for INR testing in clinical and point-of-care settings. Enables rapid anticoagulation management with minimal sample volume.

Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.

A portable point-of-care thromboelastography platform for rapid platelet function and hemostasis assessment in emergency departments, clinics, operating rooms, and ICUs. This device helps clinicians quickly understand patient hemostatic status and assists in real-time decision-making for treatment strategies. The analyzer enables rapid assessment of bleeding risk and guides appropriate antiplatelet therapy selection.

A handheld point-of-care device for coagulation measurement. Used in hospitals, clinical laboratories, and blood banks for rapid coagulation assessment.

Point-of-care testing device designed for rapid diagnosis of acute and chronic diseases. Enables immediate diagnostic results at the patient location, supporting timely clinical decision-making.

A Point-of-Care Testing (POCT) system that enables fast diagnosis at the point of care. It provides rapid diagnostic results for timely clinical decision-making.

Integrated assessment protocol combining transcranial Doppler findings with clinical data for cerebrovascular risk evaluation. Identifies high-risk patients requiring intervention.

Epigenetic-based diagnostic test for early detection of cerebrovascular disease and stroke risk. Developed in collaboration with Beijing Tiantan Hospital, this test supports stroke prevention initiatives. The product integrates findings from a large-scale stroke cohort study.

Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.